Journal of Rheumatic Diseases

Scope & Guideline

Unlocking the potential of rheumatology through shared knowledge.

Introduction

Immerse yourself in the scholarly insights of Journal of Rheumatic Diseases with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2093-940x
PublisherKOREAN COLL RHEUMATOLOGY
Support Open AccessYes
CountrySouth Korea
TypeJournal
Convergefrom 2019 to 2024
AbbreviationJ RHEUMAT DIS / J. Rheum. Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRAEMIAN YONGSAN A BLDG 1917, 95 HANGANG-DAERO, YONGSAN-GU, SEOUL 04378, SOUTH KOREA

Aims and Scopes

The Journal of Rheumatic Diseases focuses on advancing knowledge in rheumatology through original research, reviews, and case reports. It aims to address various aspects of rheumatic diseases, including their epidemiology, pathophysiology, diagnosis, treatment, and patient outcomes.
  1. Clinical Research in Rheumatology:
    The journal publishes studies that explore the clinical characteristics, treatment responses, and outcomes of patients with various rheumatic diseases, contributing valuable data to the field.
  2. Innovative Therapeutic Approaches:
    A significant emphasis is placed on research involving new therapeutic strategies, including biologics, disease-modifying antirheumatic drugs (DMARDs), and emerging treatments for rheumatic conditions.
  3. Epidemiology and Disease Patterns:
    The journal includes epidemiological studies that investigate the prevalence, risk factors, and demographic characteristics of rheumatic diseases, particularly within specific populations.
  4. Pathophysiology and Mechanistic Studies:
    Research delving into the underlying biological mechanisms of rheumatic diseases, including genetic, immunological, and environmental factors, is a key focus area.
  5. Patient-Centered Outcomes and Quality of Life:
    The journal highlights studies that assess patient-reported outcomes, quality of life, and the psychosocial aspects of living with rheumatic diseases.
  6. Multidisciplinary Approaches:
    The journal recognizes the importance of multidisciplinary care in rheumatology, encouraging submissions that explore collaborations between rheumatologists, physiotherapists, and other healthcare providers.
Recent publications in the Journal of Rheumatic Diseases indicate a shift towards emerging themes that reflect current trends in rheumatology research. These themes are increasingly relevant to contemporary clinical practice and patient management.
  1. Biologics and Targeted Therapies:
    There is a growing body of research focusing on the effectiveness and safety of biologic therapies in various rheumatic diseases, indicating a trend towards personalized medicine and tailored treatment strategies.
  2. Impact of COVID-19 on Rheumatic Diseases:
    Research examining the implications of COVID-19 on patients with rheumatic diseases, including vaccination responses and disease management during the pandemic, has surged, reflecting the ongoing relevance of this global health crisis.
  3. Machine Learning and Predictive Analytics:
    The application of machine learning models and predictive analytics in rheumatology to forecast disease progression and treatment outcomes is emerging as a significant theme, showcasing the integration of technology in clinical practice.
  4. Patient Education and Empowerment:
    Studies emphasizing the importance of patient education, self-management, and shared decision-making in the management of rheumatic diseases are increasingly featured, highlighting a shift towards patient-centered care.
  5. Long-term Outcomes and Quality of Life Assessments:
    Research focusing on long-term outcomes, including renal prognosis and quality of life in patients with chronic rheumatic diseases, is becoming more prominent, reflecting a holistic approach to patient care.

Declining or Waning

While the Journal of Rheumatic Diseases has consistently focused on several core themes, some areas of research have shown a decline in prominence over the recent years, reflecting shifts in clinical interest and advancements in the field.
  1. Traditional Treatments and Conventional Therapies:
    Research focused solely on traditional DMARDs and older treatment modalities has decreased, likely due to the rise of biologics and targeted therapies, which are becoming the standard of care.
  2. Basic Science without Clinical Relevance:
    Studies that explore basic science aspects of rheumatology without a clear clinical application or relevance have become less frequent, as the journal aims to prioritize research that directly impacts patient care.
  3. Single-Center Studies:
    The prevalence of single-center studies has decreased as the journal favors larger, multi-center studies that provide more robust data and generalizability of findings.
  4. Non-Interventional Observational Studies:
    There appears to be a waning interest in non-interventional observational studies that do not offer new insights into treatment efficacy or patient outcomes, as the field moves towards more rigorous interventional research.

Similar Journals

Advances in Rheumatology

Empowering discoveries in rheumatic disease management.
Publisher: BMCISSN: 2523-3106Frequency: 1 issue/year

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.

Arthritis & Rheumatology

Connecting Researchers to Transformative Discoveries
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Advancing Knowledge in Rheumatology
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1076-1608Frequency: 8 issues/year

JCR-Journal of Clinical Rheumatology, published by Lippincott Williams & Wilkins, is a premier outlet dedicated to the field of rheumatology, recognized for its contributions and relevance among medical journals. Boasting an impact factor reflective of its vital role in disseminating innovative research, it currently holds a Q2 category ranking in Medicine (miscellaneous) and a Q3 ranking in Rheumatology as of 2023. With its convergence years spanning from 1995 to 2024, the journal aims to foster the advancement of knowledge in clinical practices, therapeutic advances, and patient management strategies concerning rheumatic diseases. Researchers, professionals, and students can access a wealth of benchmark studies and peer-reviewed articles, enhancing their understanding and collaboration within this dynamic field. By bridging clinical insights with rigorous research, the JCR-Journal of Clinical Rheumatology remains an important resource for advancing the understanding of rheumatologic disorders and improving patient care.

RHEUMATOLOGY INTERNATIONAL

Empowering researchers and clinicians with vital insights.
Publisher: SPRINGER HEIDELBERGISSN: 0172-8172Frequency: 12 issues/year

Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.

Nature Reviews Rheumatology

Connecting global expertise in rheumatology.
Publisher: NATURE PORTFOLIOISSN: 1759-4790Frequency: 12 issues/year

Nature Reviews Rheumatology is a premier academic journal published by NATURE PORTFOLIO, dedicated to the field of rheumatology. With an impressive impact factor reflecting its high citation rate and relevance within the scientific community, it ranks in the Q1 category for rheumatology, showcasing its essential role in disseminating cutting-edge research and reviews. The journal serves as a vital resource for researchers, clinicians, and students alike, presenting comprehensive articles that cover the latest developments, therapeutic advancements, and emerging trends in rheumatic diseases. With access options, including open access, it ensures that valuable insights are within reach for all stakeholders in the field. Situated in the United Kingdom and intersecting with a global audience, Nature Reviews Rheumatology stands as an authoritative voice, fostering education and innovation to improve patient outcomes and enhance the understanding of rheumatological conditions.

SEMINARS IN ARTHRITIS AND RHEUMATISM

Connecting professionals with cutting-edge research.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0049-0172Frequency: 6 issues/year

SEMINARS IN ARTHRITIS AND RHEUMATISM, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of rheumatology and pain medicine. With an impressive impact factor and recognized as a Q1 journal in both its categories, it ranks #8 in Anesthesiology and Pain Medicine and #11 in Rheumatology based on the latest Scopus data, placing it within the top echelons of academic research. Established in 1971, this esteemed publication offers a comprehensive platform for researchers and practitioners to disseminate and engage with cutting-edge studies that advance the understanding and treatment of arthritis and related conditions. With its robust editorial process and focus on high-quality, peer-reviewed articles, the journal not only contributes to scientific knowledge but also serves as an essential resource for professionals and students seeking contemporary insights into effective management strategies and emerging therapies in the rheumatologic field. Although it does not offer open access, its subscription model ensures a wide distribution among academic and clinical institutions, reinforcing its significance in the research community.

AKTUELLE RHEUMATOLOGIE

Transforming rheumatology through shared knowledge and research.
Publisher: GEORG THIEME VERLAG KGISSN: 0341-051XFrequency: 6 issues/year

AKTUELLE RHEUMATOLOGIE is a prominent German journal published by GEORG THIEME VERLAG KG, dedicated to advancing the field of rheumatology. Since its inception in 1978, this peer-reviewed journal has been a vital resource for professionals, researchers, and students engaged in the study and treatment of rheumatic diseases. With an ISSN of 0341-051X and an E-ISSN of 1438-9940, the journal provides a platform for sharing groundbreaking research, clinical studies, and reviews. Although classified in the fourth quartile (Q4) of rheumatology journals and ranked 67 out of 73 in its category according to Scopus, AKTUELLE RHEUMATOLOGIE continues to contribute to the discourse in rheumatology. Its comprehensive coverage of recent advancements and innovative approaches makes it an essential publication for anyone interested in the latest developments in the field.

Indian Journal of Rheumatology

Championing research that transforms rheumatologic practices.
Publisher: SAGE PUBLICATIONS INCISSN: 0973-3698Frequency: 4 issues/year

Welcome to the Indian Journal of Rheumatology, a premier scholarly platform dedicated to advancing research and clinical practice in the field of rheumatology. Published by SAGE Publications Inc., this journal has been providing open access to its valuable content since 2006, promoting the dissemination of knowledge in India and beyond. As a voice in the rheumatology community, the journal addresses a wide range of topics including epidemiology, diagnostics, treatment strategies, and patient care in rheumatic diseases. Despite being classified in the Q4 category of the 2023 Scopus rankings, with a current position of Rank #57 among 73 journals, it serves as an essential resource for researchers, healthcare professionals, and students seeking to stay updated with the latest developments. The journal is committed to fostering scholarly dialogue and facilitating access to research that influences practice and improves patient outcomes in rheumatologic care.

Current Rheumatology Reviews

Elevating standards in rheumatic disease research.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-3971Frequency: 3 issues/year

Current Rheumatology Reviews is an esteemed journal dedicated to publishing comprehensive reviews on advancements in the field of rheumatology. Established by Bentham Science Publishers, this journal has become a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments and therapeutic strategies from 2006 to 2024. Located in the United Arab Emirates, it caters to a global audience, delivering insights that have been pivotal in shaping clinical practices. With an impact factor reflective of its Q3 status in Rheumatology by 2023, the journal ranks #46 out of 73 in the Scopus database, positioning it in the 37th percentile in the discipline. Although it operates without open access, its high-quality content ensures that each article undergoes rigorous peer review, making the Current Rheumatology Reviews a trusted platform for disseminating critical research findings and reviews that drive forward the understanding and treatment of rheumatic diseases.

Reumatologia

Fostering collaboration in the fields of Immunology and Rheumatology.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 0034-6233Frequency: 6 issues/year

Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.